edetic acid has been researched along with meropenem in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
| Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J | 1 |
| Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Bai, Y; Gan, M; Gao, R; Guan, Y; He, W; Li, L; Li, Y; Liu, Y; Xiao, C; You, X; Yu, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chu, WC; Han, JX; Huang, SC; Qin, S; Shi, XF; Wang, MM; Xiao, C; Zhang, E | 1 |
| Brunst, S; Burgers, LD; Frank, D; Fürst, R; Gobec, S; Martinelli, G; Proschak, A; Proschak, E; Rotter, MJ; Sosič, I; Weizel, L; Wichelhaus, TA | 1 |
| Chen, F; Hu, L; Ji, C; Liu, R; Mao, W; Wang, H; Xie, H; Xue, S; Yang, H; Yu, T; Zhang, S | 1 |
| Church, DL; Gregson, DB; Le, P; McClure, JA; Pitout, JD; Poirel, L | 1 |
| Goessens, WH; Mol, M; Pitout, JD; van der Bij, AK; van Westreenen, M | 1 |
| Breeze, AL; Gao, N; Hu, J; Ma, J; MacCormack, K; McLeod, S; Sriram, S | 1 |
| Cantón, R; Costa-de-Oliveira, S; Espinar, MJ; Faria-Ramos, I; Miranda, IM; Pina-Vaz, C; Ricardo, E; Rodrigues, AG; Silva, AP | 1 |
| Acar, Z; Johansson, ÅC; Justesen, US; Schwensen, SA; Sydenham, TV | 1 |
| Kulkarni, S; Maddani, S; Munshi, N; Sathe, P | 1 |
| Asempa, TE; Kois, AK; Nicolau, DP | 1 |
1 review(s) available for edetic acid and meropenem
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for edetic acid and meropenem
| Article | Year |
|---|---|
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA | 2007 |
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam | 2007 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Polyketides with New Delhi metallo-β-lactamase 1 inhibitory activity from Penicillium sp.
Topics: Alkaloids; beta-Lactamase Inhibitors; beta-Lactamases; China; Circular Dichroism; Crystallography, X-Ray; Inhibitory Concentration 50; Molecular Structure; Penicillium; Polyketides; Quinolones; Rhizosphere | 2013 |
H
Topics: beta-Lactamases; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacter; Enzyme Inhibitors; Escherichia coli; Ethylamines; Ligands; Meropenem; Pyridines | 2019 |
Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroquinolines; Recombinant Proteins; Structure-Activity Relationship | 2022 |
Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins | 2022 |
Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory.
Topics: Alberta; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Edetic Acid; Humans; Imipenem; Laboratories; Meropenem; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Pseudomonas aeruginosa; Regional Health Planning; Sensitivity and Specificity; Thienamycins | 2005 |
The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Edetic Acid; Humans; Imipenem; Laboratories; Meropenem; Microbial Sensitivity Tests; Netherlands; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; Thienamycins | 2011 |
Real-time monitoring of New Delhi metallo-β-lactamase activity in living bacterial cells by 1H NMR spectroscopy.
Topics: Anti-Bacterial Agents; beta-Lactamases; Captopril; Drug Resistance, Bacterial; Edetic Acid; Enzyme Inhibitors; Escherichia coli; Hydrolysis; Magnetic Resonance Spectroscopy; Meropenem; Spermine; Thienamycins | 2014 |
Rapid Flow Cytometry Test for Identification of Different Carbapenemases in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Boronic Acids; Cloxacillin; Edetic Acid; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Flow Cytometry; Gene Expression; Humans; Meropenem; Penicillins; Thienamycins | 2016 |
Phenotypic detection of the cfiA metallo-β-lactamase in Bacteroides fragilis with the meropenem-EDTA double-ended Etest and the ROSCO KPC/MBL Confirm Kit.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; beta-Lactamases; Disk Diffusion Antimicrobial Tests; Edetic Acid; Meropenem; Reagent Kits, Diagnostic; Thienamycins | 2017 |
Management of ventilator associated pneumonia with a new antibiotic adjuvant entity (ceftriaxone+sulbactam+disodium edetate) - A novel approach to spare carbapenems.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Chemotherapy, Adjuvant; Colistin; Cross Infection; Drug Therapy, Combination; Edetic Acid; Female; Humans; Intensive Care Units; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Thienamycins | 2017 |
In vivo exposure-response relationship of meropenem against metallo-β-lactamase-harbouring Pseudomonas aeruginosa: an assessment using MICs from conventional and zinc-limited broth.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Edetic Acid; Meropenem; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Zinc | 2022 |